EUVIMEDEUVIMED entdecken
Crossref

Beneficial Effect of Xanthohumol Supplementation on the Clinical Course of IgA Nephropathy Refractory to Conventional Treatment—A Prospective, Open‐Label Case Series

Andrzej Jaroszyński, Wojciech Dabrowski, Mariusz Gagoś, Agnieszka Perkowska-Ptasińska, Jan F Stevens

Molecular Nutrition & Food Research · 2026-03 · 70 (6)

DOI: 10.1002/mnfr.70439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 12.03.2026. Verfasst von Andrzej Jaroszyński und 4 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Department of Internal Medicine and Family Medicine, Jan Kochanowski University in Kielce, Kielce, Poland. Hauptthemen laut MEDLINE: Propiophenones, Glomerulonephritis, IGA, Flavonoids, Dietary Supplements. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Medical University in Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide. Xanthohumol (XN) exhibits anti‐inflammatory, anti‐oxidant, anti‐fibrotic, anti‐microbial, anti‐proliferative, and immunomodulatory effects that all are associated with the IgAN pathogenesis. Our study aims to evaluate the potential impact of XN on the clinical course of IgAN refractory to conventional treatment. Included were five rigorously selected IgAN patients with poor prognosis assessed on the basis of clinical findings and renal biopsy. Patients received XN orally at a daily dose of 2 mg/kg body weight. Biochemical tests were performed the day before the start of XN administration, and then after 2, 4, 12, 24, and 52 weeks of XN administration. XN induced a decrease in daily proteinuria in all patients. Compared to baseline values, at T52 the mean reduction in proteinuria and albumin‐creatinine‐ratio was 45.3% and 48.4% respectively ( p < 0.001 in both cases). Reduction of urine erythrocyturia occurred in four out of five patients. No progression of chronic kidney disease was observed in any patient. No adverse effects of XN were observed, and XN was well tolerated. XN supplementation has potential as an additive treatment for IgAN patients. Moreover, XN appears to be safe and well tolerated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropiophenonesGlomerulonephritis, IGAFlavonoidsDietary SupplementsHumansMaleFemaleAdultProspective StudiesProteinuriaMiddle AgedCreatinineKidney

Stichwörter der Autor:innen

IgA nephropathyerythrocyturiaflavonoidsproteinuriaxanthohumol

Substanzen

PropiophenonesxanthohumolFlavonoidsCreatinine

Autor:innen und Institutionen

  • Collegium Medicum, Department of Internal Medicine and Family Medicine, Jan Kochanowski University in Kielce, Kielce, Poland.
  • Department of Nephrology, Regional Hospital of Stalowa Wola, Stalowa Wola, Poland.
  • First Department of Anaesthesiology and Intensive Therapy, Medical University in Lublin, Lublin, Poland.
  • Department of Cell Biology, Maria Curie-Sklodowska University, Akademicka 19, Lublin, Poland.
  • Department of Pathology, Medical University of Warsaw, Warsaw, Poland.
  • Department of Pharmaceutical Sciences and the Linus Pauling Institute, Oregon State University, Corvallis, Oregon, USA.

Förderung

  • Medical University in Lublin

Zitieren

APA

Jaroszyński, A., Dabrowski, W., Gagoś, M., Perkowska-Ptasińska, A., & Stevens, J. F. (2026). Beneficial Effect of Xanthohumol Supplementation on the Clinical Course of IgA Nephropathy Refractory to Conventional Treatment—A Prospective, Open‐Label Case Series. Molecular Nutrition & Food Research, 70(6). https://doi.org/10.1002/mnfr.70439

Vancouver

Jaroszyński A, Dabrowski W, Gagoś M, Perkowska-Ptasińska A, Stevens JF. Beneficial Effect of Xanthohumol Supplementation on the Clinical Course of IgA Nephropathy Refractory to Conventional Treatment—A Prospective, Open‐Label Case Series. Molecular Nutrition & Food Research. 2026;70(6). doi:10.1002/mnfr.70439

BibTeX
@article{Jaroszyski2026,
  author = {Jaroszyński, Andrzej and Dabrowski, Wojciech and Gagoś, Mariusz and Perkowska-Ptasińska, Agnieszka and Stevens, Jan F},
  title = {Beneficial Effect of Xanthohumol Supplementation on the Clinical Course of IgA Nephropathy Refractory to Conventional Treatment—A Prospective, Open‐Label Case Series},
  journal = {Molecular Nutrition & Food Research},
  year = {2026},
  volume = {70},
  number = {6},
  doi = {10.1002/mnfr.70439}
}
Kostenlos starten →